CLINICAL STUDY: NEW METHODS
Noninvasive single-beat determination of left ventricular end-systolic elastance in humans
Chen-Huan Chen, MDa,b,
Barry Fetics, BEc,
Erez Nevo, MD, DScc,
Carlos E. Rochitte, MDc,
Kuan-Rau Chiou, MDa,b,
PhillipYu-An Ding, MD, PhDa,b,
Miho Kawaguchi, MDc and
David A. Kass, MDc,*
a Division of Cardiology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C. Taiwan
b National Yang-Ming University, Taipei, Taiwan, R.O.C. Taiwan
c Division of Cardiology, Department of Internal Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
Manuscript received March 9, 2001;
revised manuscript received July 25, 2001,
accepted August 20, 2001.
* Reprint requests and correspondence: Dr. David A. Kass, Halsted 500, Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287 USA.
dkass{at}bme.jhu.edu
 |
Abstract
|
|---|
OBJECTIVES: The goal of this study was to develop and validate a method to estimate left ventricular end-systolic elastance (Ees) in humans from noninvasive single-beat parameters.
BACKGROUND: Left ventricular end-systolic elastance is a major determinant of cardiac systolic function and ventricular-arterial interaction. However, its use in heart failure assessment and management is limited by lack of a simple means to measure it noninvasively. This study presents a new noninvasive method and validates it against invasively measured Ees.
METHODS: Left ventricular end-systolic elastance was calculated by a modified single-beat method employing systolic (Ps) and diastolic (Pd) arm-cuff pressures, echo-Doppler stroke volume (SV), echo-derived ejection fraction (EF) and an estimated normalized ventricular elastance at arterial end-diastole (ENd): Ees(sb) = [Pd – (ENd(est) x Ps x 0.9)[/(ENd(est) x SV). The ENd was estimated from a group-averaged value adjusted for individual contractile/loading effects; Ees(sb) estimates were compared with invasively measured values in 43 patients with varying cardiovascular disorders, with additional data recorded after inotropic stimulation (n = 18, dobutamine 5 to 10 µg/kg per min). Investigators performing noninvasive analysis were blinded to the invasive results.
RESULTS: Combined baseline and dobutamine-stimulated Ees ranged 0.4 to 8.4 mm Hg/ml and was well predicted by Ees(sb) over the full range:  (r = 0.91, SEE = 0.64, p < 0.00001, n = 72). Absolute change in Ees(sb) before and after dobutamine also correlated well with invasive measures:  (r = 0.88, p < 0.00001). Repeated measures of Ees(sb) over two months in a separate group of patients (n = 7) yielded a coefficient of variation of 20.3 ± 6%.
CONCLUSIONS: The Ees can be reliably estimated from simple noninvasive measurements. This approach should broaden the clinical applicability of this useful parameter for assessing systolic function, therapeutic response and ventricular-arterial interaction.
|
Abbreviations and Acronyms
| | Ed | | left ventricular end-diastolic elastance | | Ees | | left ventricular end-systolic elastance | | Ees(sb) | | left ventricular elastance at end-systole derived by single-beat technique | | EF | | ejection fraction | | ENd(avg) | | group-averaged normalized left ventricular elastance at the onset of ejection | | ENd(est) | | noninvasive estimated normalized left ventricular elastance at the onset of ejection | | ESPVR | | end-systolic pressure volume relation | | LV | | left ventricle or left ventricular | | Pd | | diastolic arterial pressure at the onset of ejection | | Pes | | left ventricular end-systolic pressure | | Ps | | systolic arterial pressure at the onset of ejection | | SV | | stroke volume | | Vd | | left ventricular volume at the onset of ejection | | Ved | | left ventricular end-diastolic volume | | Ves | | left ventricular end-systolic volume | | V0 | | volume axis intercept of the end-systolic pressure volume relation |
|
The effectiveness of chronic heart failure therapy depends upon an accurate assessment of the underlying pathophysiology, accompanied by close patient monitoring and tailored treatment (1–3). Such comprehensive management approaches stabilize acute exacerbations, reduce readmissions, enhance quality of life and improve survival (1–3). However, variability of disease presentation and its response to treatment (3–5) and a growing complexity of therapeutic options have increased the need for more specific and better measures of cardiac performance.
Routine approaches for assessing left ventricular (LV) function are based largely on image-analysis or right-heart monitoring. Both are useful yet provide limited information specific to the LV, and neither indexes ventricular-arterial interactions, which can be crucial for optimizing chronic therapy (6–9). The end-systolic pressure-volume relation (ESPVR) and its slope (Ees) have proven very useful in this regard since Ees is a major determinant of LV systolic performance and heart interaction with the systemic vasculature (8–13). However, Ees determination has generally required invasively measured LV pressure and volumes recorded over a range of cardiac loading. This has hampered the broader application of this parameter to clinical heart failure diagnosis and management.
Several approaches have been proposed for estimating Ees without loading interventions (14–16), and these are generally referred to as single-beat methods (Ees(sb)). For example, based on similarities between the amplitude and time-normalized human LV time-varying elastance curves during early isovolumic contraction, we reported that Ees could be estimated from steady-state data (15). This approach has been since applied to other species as well (17). Subsequent studies (16) improved on this approach by individually adjusting the normalized elastance curve to compensate for load and contractility dependencies.
A strength of these particular methods (14,16) is their potential to be used noninvasively. While this has already been attempted (18), there are no data validating the noninvasive approach by comparing it with directly measured (multiple-cycle derived) invasive Ees. In this study, we developed a modified noninvasive method for Ees(sb) and verified this method by comparisons with results obtained from invasive (multiple-beat) analysis.
|
Methods
|
|---|
Study population.
The primary study group consisted of 43 patients studied in the cardiac catheterization laboratories of the Johns Hopkins Hospital (n = 11) or Taipei Veterans General Hospital, Taiwan (n = 32). Invasive and noninvasive pressure-volume data were measured simultaneously at the first center and within 1 to 2 h of each other at the latter center. For simultaneous studies, a custom light-weight radio-lucent horizontal tilt-table was attached to the catheterization table to position patients for echo-Doppler recording. Thirty-four men and nine women were studied, with a mean age of 62 ± 12 years. Primary indications for cardiac catheterization were chest pain (n = 26) or heart failure (n = 17). Clinical diagnoses included noncardiac disease (normal coronary artery anatomy and LV systolic function, n = 13), coronary artery disease (n = 13), hypertensive cardiac disease (n = 8), dilated cardiomyopathy (n = 5), hypertrophic cardiomyopathy (n = 1), constrictive pericarditis (n = 1) and heart transplantation (n = 2). Ejection fraction (EF) ranged from 17% to 88% (mean: 69 ± 15%).
Additional studies were obtained by noninvasive method in seven subjects with vascular stiffening and normal heart function (placebo arm of pharmacologic study) to test measurement reproducibility over time. All patients provided informed consent, and the relevant institutional review board for each respective institution approved the protocol(s).
Study protocol
Patients underwent routine coronary angiography, left ventriculography and right heart catheterization. A 7F multielectrode conductance/micromanometer catheter was then placed into the LV, with the pigtail tip advanced to the ventricular apex. Left ventricular volumes were recorded using a stimulator-microprocessor (Sigma V, CardioDynamics, the Netherlands) and calibrated to match thermodilution-derived stroke volume (SV) and contrast ventriculogram-derived EF. Echocardiograms were performed (Agilent, Sonos-5500, Palo Alto, California) using a wide-band frequency-fusion phase-array transducer. Brachial systolic (Ps) and diastolic (Pd) blood pressures were obtained with an oscillometric blood pressure monitor. End-systolic pressure (Pes) was estimated from Ps x 0.9 (19). This was further tested in 17 subjects in whom concomitant brachial cuff pressure and invasive data were measured, yielding a linear relation with slope 1.01, p < 0.0001, r = 0.75. Left ventricular outflow tract diameter was measured at the base of the aortic leaflets in a parasternal long-axis view from which cross-sectional area was determined. Stroke volume was measured from proximal aorta pulse-wave Doppler-flow (apical five-chamber view) and aortic cross-sectional area (20). A standard method was used to calculate LV EF from two-dimensional guided M-mode echocardiographic data (21).
In addition to rest data, noninvasive and invasive assessments were made in 18 patients before and after varying contractility by dobutamine (5 to 10 µg/kg per min, intravenous). Comparisons were simultaneous in five studies and sequential (separated by 1 to 2 h) in the others. A total of 29 prepost dobutamine comparisons were obtained (two doses in most patients).
Ees(sb) estimation algorithm
The algorithm for Ees(sb) assumed a linear end-systolic pressure-volume relation in the measured data range and a constant volume axis intercept of the end-systolic pressure volume relation (V0). Using pressures and volumes determined during midisovolumic contraction (td) and at end-systole (tes), two values of LV elastance were derived:  and  . Their ratio ENd (Ed/Ees) was the time and amplitude normalized time varying elastance at time td. We found that values of ENd were conserved during the isovolumic period in humans despite diverse cardiac disease, heart function and arterial load. Thus, knowledge of td meant that ENd and, thereby, Ees and V0 could be derived (14).
The prior study of Senzaki et al. (14) sampled pressures and volumes at several time points during isovolumic contraction (i.e., multiple values of td). This was easily achieved since both signals were measured invasively, and the final Ees estimate averaged separate calculations. For noninvasive analysis, however, a single pressure-volume point is used, timed at the onset of ejection (end of the isovolumic period). By substituting arterial diastolic pressure for end-isovolumic LV pressure and arterial systolic pressure for LV end-systolic pressure, one obtains (see Appendix for details):
 | (1) |
where Ved and Ves are end-diastolic and end-systolic volumes, SV is stroke volume, ENd is the normalized elastance value at the onset of ejection and Pd and Pes are arterial diastolic and end-systolic pressures, respectively.
The accuracy of equation 1 is dependent on the reliability of the measured data and the value chosen for ENd. Our prior study employed high-fidelity pressure/volume signals to yield accurate timing for ENd determination and early isovolumic contraction data to minimize intrapatient variability about the group-averaged normalized LV elastance at the onset of ejection (ENd(avg)) value. For noninvasive application, ENd occurs at the onset of ejection, increasing individual load/contractile-dependent deviations from the population average. To reduce this variance, we developed an approach similar to that of Shishido et al. (16) using a regression model to improve the individual noninvasive estimated normalized LV elastance at the onset of ejection (ENd(est)) for each patient, based on noninvasive measures of systolic function (EF) and arterial load (ratio of arterial diastolic to systolic pressure).
The ENd(est) regression-model was based on data obtained in 23 completely separate and previously recorded studies in which invasive aortic pressure and LV pressure-volume data were concomitantly measured. An individual time-varying elastance function was calculated from rest steady-state data, with V0 in this calculation based on multicycle ESPVR analysis as previously described (14). This curve was normalized by amplitude and time, and its value at the upstroke of aortic pressure determined. This served as the "gold standard" value for ENd. The ENd(est) was obtained from a group-averaged normalized elastance curve value at this same time td (ENd(avg)), baseline EF and the ratio of arterial diastolic to systolic pressure (Pd/Pes), given by:
 | (2) |
where ENd(avg) is given by a seven-term polynomial function:
.
where ai are (0.35695, –7.2266, 74.249, –307.39, 684.54, –856.92, 571.95, –159.1) for i = 0 to 7, respectively. The value of tNd was determined by the ratio of pre-ejection period (R wave  flow-onset) to total systolic period (R-wave end-flow), with the time at onset and termination of flow defined noninvasively from the aortic Doppler waveform. Each factor in equation 2 was a significant independent contributor to the regression. Figure 1 compares ENd(est) with directly measured ENd. The regression yielded an overall r = 0.88 and p < 0.00001, with a SEE about 10% the mean. The Ees(sb) was then derived by combining equations 1 and 2:
 | (3) |
View larger version (21K):
[in this window]
[in a new window]
|
Figure 1 Estimation of normalized time-varying elastance value at the onset of ejection for individual subjects. The estimate is based on the group-averaged value (14), resting ejection fraction and the ratio of diastolic to systolic arterial pressure (equation 2). Plot shows correlation between predicted normalized left ventricular elastance at the onset of ejection (ENd) and directly measured value.
|
|
Statistical methods
Results are expressed as mean ± SD. Univariate linear regression was performed to test the agreement between noninvasively estimated and invasively measured Ees values at rest and changes in Ees induced by dobutamine. Bland-Altman analysis was employed to assess for systematic bias in the correlation.
|
Results
|
|---|
Estimation of Ees by Ees(sb).
Figure 2A displays typical pressure-volume loop data used to derive invasive Ees. The ESPVRs were generally linear over the observed data range. Figure 2B shows the corresponding noninvasive analysis displayed as two pressure-volume points (solid and open circles). From these points, equations 1 and 2 were used to determine Ees(sb). Figure 2C and 2D show similar examples before and after dobutamine infusion. The plots demonstrate a generally good correlation between directly measured Ees and the noninvasive estimate.
View larger version (45K):
[in this window]
[in a new window]
|
Figure 2 (A) Invasive pressure-volume loops and analysis used to derive (Ees). Multiple beats are recorded before and during transient obstruction of the inferior vena cava. (B) Noninvasive assessment of (Ees(sb)) displayed in pressure-volume plane from the same example. Two sets of (volume, pressure) data points are measured and used to predict Ees(sb). The dotted area represents a schematic pressure-volume loop based on these points. From these data, Ees(sb) is estimated using equation 4. (C) Example of pressure-volume data at rest and after dobutamine stimulation. (D) Corresponding noninvasive Ees(sb) for the same example displayed in C. Darkened areas are schematic loops from the two points. Pd = diastolic arterial pressure at the onset of ejection; Pes = left ventricular end-systolic pressure; SV = stroke volume; Ved = left ventricular end-diastolic pressure; Ves = left ventricular end-systolic volume.
|
|
Figure 3A displays group regression results for 43 baseline comparisons between invasive Ees and the single-beat noninvasive Ees(sb) estimate. The regression equation was:  (r = 0.81, SEE = 0.50, p < 0.0001). The mean difference was 0.03 mm Hg/ml (95% confidence interval: –0.14 0.19), that is, no systematic bias, and 80% of the estimate errors fell below 0.6 mm Hg. Figure 3C shows combined baseline and postdobutamine data, extending the range of Ees comparisons nearly twofold and improving the strength of the overall correlation. The regression SEE was 0.64, with the mean error of 0.43 ± 0.5 (again with no bias) and with about 75% of the estimates falling within 0.6 mm Hg/ml of the measured value.
View larger version (27K):
[in this window]
[in a new window]
|
Figure 3 (A) Linear regression (solid line) and 95% confidence intervals (dotted lines) comparing noninvasive left ventricular elastance at end-systole derived by single-beat technique (Ees(sb)) and invasive (multi-beat) left ventricular end-systolic elastance (Ees) at baseline for 43 subjects. (B) Bland-Altman plot of Ees(sb)-Ees difference versus mean value. Mean and 99% confidence interval of the mean difference is shown. (C and D) Same analysis as in A and B but including data after dobutamine stimulation, which expanded the range of Ees comparisons. The correlation between measurements is very good and falls along the line of identity.
|
|
Relative changes in Ees by dobutamine
To further test the robustness of the noninvasive method, the estimated change in Ees induced by dobutamine in each patient was compared with the directly measured change based on invasive loop analysis (Fig. 3C and 3D) . The results (Fig. 4) revealed a good correlation given by:  (r = 0.88, SEE = 0.67, p < 0.0001).
Comparison with Pes/Ves ratio
The steady-state ratio of end-systolic pressure to end-systolic volume (Pes/Ves) is the most commonly employed approximation for Ees, particularly for noninvasive use. It makes a simple assumption that the volume axis intercept of the ESPVR is zero. To determine if the Ees(sb) provided additional accuracy over this more easily measured ratio, we compared Pes/Ves to invasive Ees. The results shown in Figure 5 demonstrate that Pes/Ves was less well-correlated with Ees (r = 0.56) compared with Ees(sb) and consistently overestimated Ees, particularly at higher values. The residuals (Fig. 5B) were significantly different from zero, averaging 2.2 mm Hg/ml. This result contrasts with that for Ees(sb), which yielded a relation closer to the identity line.
View larger version (17K):
[in this window]
[in a new window]
|
Figure 5 Comparison of resting end-systolic pressure/volume ratio (Pes/Ves) as an estimate of elastance to directly measured left ventricular end-systolic elastance (Ees) by invasive analysis. Unlike Ees(sb) (Fig. 3B), the pressure-volume ratio consistently overestimated directly measured Ees, and the regression had a non-zero bias (2.2 mm Hg/ml) as demonstrated in the lower Bland-Altman plot.
|
|
Reproducibility of Ees(sb)
To test the chronic reproducibility of Ees(sb) measurements, the noninvasive parameter was measured over three successive months in seven subjects with systolic hypertension enrolled in a randomized placebo-controlled trial of a novel antihypertension agent. These patients were those subsequently found to be on placebo. Data were obtained at baseline and monthly for two months, each measured in a fasting state in the morning. Mean Ees(sb) was 3.3 ± 0.94, 3.6 ± 1.3 and 3.1 ± 1.1 at the three observation points, with an average coefficient of variation of 20 ± 6%. Variability of Ees(sb) was primarily related to that of SV (cov = 14 ± 6.6%).
|
Discussion
|
|---|
We developed and tested a novel fully noninvasive method for estimating Ees. The method requires five easily measured parameters obtained from noninvasive arm-cuff blood pressures, echo-Doppler cardiography and the electrocardiogram. This is the only study to date to directly verify a fully noninvasive estimation method against invasive multiple cycle-derived pressure-volume relations in humans.
The correlations between measured and estimated Ees(sb) values at rest and with acute contractility change were generally good, and there was reasonable repeated-measurement reproducibility over time. It is important in this regard to consider the accuracy of the new estimation method relative to likely clinical applications. The majority (between 75% to 80%) of absolute discrepancies between Ees(sb) and the invasive "goal-standard" value were smaller than 0.6 mm Hg/ml (consistent with SEE from regression analysis). The Ees typically ranges near 2.0 mm Hg/ml in normal hearts (13), <1.0 mm Hg/ml in dilated failing hearts (12) and about 4.0 mm Hg/ml in hypertrophied hearts (22). Thus, an absolute error of 0.6 mm Hg should be adequate to correctly identify most patients within these populations. The 20% variability observed with repeated measures suggests that Ees(sb) estimates are unlikely to cross between disease groups by pure chance. However, it also indicates that moderate changes are likely needed for the new method to detect real alterations in Ees(sb) over time or with interventions.
Comparison with other single-beat analysis methods.
Several prior studies have reported methods for estimating Ees from single-beat data. Most commonly, the Pes/Ves ratio is calculated. However, the assumption that the ESPVR passes through the origin in humans results in consistent overestimation of true Ees and substantially greater prediction variance (Fig. 5) (14). Kameyama et al. (9) used a more complex noninvasive analysis to estimate Ees based on pressure-cuff calibrated subclavian artery pulse tracings, echocardiography imaging and load interventions. This approach, and recent adaptations employing acoustic quantification methodology (23), remain limited by a need for varying load, which can result in unreliable image quantitation during the loading change. Other efforts to assess Ees involve curve fitting to the pressure waveform (15), an approach that seems less reliable than the Ees(sb) method (14) and is not translatable to noninvasive analysis.
Recently, Shishido et al. (16) proposed a bilinear approximation to the normalized time varying elastance curve (rising phase only) and found this simple fit provided a reliable estimate of Ees in anesthetized dogs. Central to their determination was individual estimation of the point at which the first linear approximation to rising elastance transited to the second, an inflection occurring at or near the onset of ejection. Rather than being independent of loading or contractile conditions, the inflection point had sensitivities that could be predicted from EF. Lack of a stable inflection point might seem to counter our prior clinical study (14) in which the elastance waveform was fairly well conserved during early systole. However, this earlier invasive analysis relied on data measured during the pre-ejection isovolumic period, when load and contractile effects on the elastance curve were minimal. In contrast, the method of Shishido et al. (16) as well as the present method relied on data measured solely at the onset of ejection, where these factors are more influential. Equation 2 in this study was developed independently yet concurrently with the approach of Shishido et al. (16) and serves the same purpose as their regression model to individualize a bilinear elastance. One noteworthy difference was that this study developed the model from an independent patient group and then applied this to a separate study population.
The new Ees(sb) method should also be contrasted to a recently described single-beat determination of preload recruitable stroke work (24). Preload recruitable stroke work is a useful systolic parameter that typically displays greater stability to varying loading over Ees and other indexes, and the recent study by Karunanithi and Feneley (24) extended this index to single-beat analysis. However, determination required invasive pressure and volume data, and it is unclear how easily or well this can be extended to noninvasive testing. Furthermore, it is more difficult to assess ventricular-arterial interaction with preload recruitable stroke work as opposed to Ees, which is an advantage for the latter in predicting systemic pressure responses to afterload or preload reduction therapy (11,13).
Study limitations
Technical limitations in the catheterization laboratory precluded simultaneous noninvasive/invasive analysis in many subjects, and those studies in which this was achieved still may not have optimized echo-Doppler imaging. However, this should have introduced greater scatter in our comparison data, not less. This study also did not evaluate the load-sensitivity of Ees(sb) but, rather, focused on the correlation between this parameter and directly measured invasive data. Prior invasive investigations of the Ees(sb) method have demonstrated the lack of loading influences (14).
As with many prior studies, the current invasive analysis frequently yielded an apparent negative V0 intercept for the ESPVR measured in the physiologic data range. This is not a unique feature of conductance catheter analysis, as similar findings have been reported in various mammalian species regardless of the volume method used and previously discussed (14) and is mostly related to nonlinear behavior of the ESPVR at highly reduced load. Importantly, the behavior of the ESVPR in the physiologic loading range defines the relevant hemodynamic responses; so Ees assessed in this range is most important. The new noninvasive algorithm was designed to estimate this operational Ees value, regardless of whether it predicted a negative (i.e., nonphysiologic) V0 based on a purely linear extrapolation.
Conclusions
Left ventricular end-systolic elastance can be estimated from easily obtained noninvasive parameters, and the values obtained are generally well correlated with directly measured data. Besides its implications regarding contractile strength, Ees values also help clarify integrated cardiovascular responses to altered vascular loading (8,11–13,25). In this important sense, it should be useful for assessing the efficacy of heart failure therapies and targeting the type of treatment most likely to prove beneficial.
|
APPENDIX
|
|---|
The ventricular elastance model for the end-systolic point is.
 | (A1) |
and for the onset of ventricular ejection point is:
 | (A2) |
Since by definition,  , equation A2 can be rewritten as:
 | (A3) |
Rearranging equation A1 and combining it with equation A3 yields:
 | (A4) |
which is then solved for Ees:
 | (A5) |
Left ventricular volume at the onset of ejection (Vd) is very close to the LV end-diastolic volume, so stroke volume (SV) can substitute for (Vd – Ves). The Pes is approximated by the product of brachial systolic pressure Ps x 0.9. Substitution of these variables in equation A5 yields equation 1 in the Methods section.
|
Footnotes
|
|---|
Supported by a grant from the National Institute on Aging (AG-12249) and intramural grants from the Veterans General Hospital-Taipei, Taiwan, R.O.C. (VGH 87-306, 88-304 and 89-257).
|
References
|
|---|
1. Stevenson LW, Massie BM, Francis GS. Optimizing therapy for complex or refractory heart failure: A management algorithm. Am Heart J. 1998;135:293–309[CrossRef][Medline]
2. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management programs on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725–732[Abstract]
3. Steimle AE, Stevenson LW, Chelimsky-Fallick C, et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation. 1997;96:1165–1172[Abstract/Free Full Text]
4. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: Trends in incidence and survival in a 10-year period. Arch Intern Med. 1999;159:29–34[Abstract/Free Full Text]
5. Vasan RS, Benjamin EJ, Levy D. Congestive heart failure with normal left ventricular systolic function: Clinical approaches to the diagnosis and treatment of diastolic heart failure. Ann Intern Med. 1996;156:146–157
6. Asanoi H, Kameyama T, Ishizaka S, Nozawa T, Inoue H. Energetically optimal left ventricular pressure for the failing human heart. Circulation. 1996;93:67–73[Abstract/Free Full Text]
7. Binkley PF, VanFossen DB, Nunziata E, Unverferth DV, Leier CV. Influence of positive inotropic therapy of pulsatile hydraulic load and ventricular-vascular coupling in congestive heart failure. J Am Coll Cardiol. 1990;15:1127–1135[Abstract]
8. Ishihara H, Yokota M, Sobue T, Saito H. Relation between ventriculoarterial coupling and myocardial energetics in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1994;23:406–416[Abstract]
9. Kameyama T, Asanoi H, Ishizaka S, Sasayama S. Ventricular load optimization by unloading therapy in patients with heart failure. J Am Coll Cardiol. 1991;17:199–207[Abstract]
10. Suga H, Sagawa K. Instantaneous pressure-volume relationships and their ratio in the exercised, supported canine left ventricle. Circ Res. 1974;35:117–126[Abstract/Free Full Text]
11. Kass DA, Maughan WL. From "Emax" to pressure-volume relations: A broader view. Circulation. 1988;77:1203–1212[Free Full Text]
12. Feldman MD, Pak PH, Wu CC, et al. Acute cardiovascular effects of OPC-18790 in patients with congestive heart failure. Circulation. 1996;93:474–483[Abstract/Free Full Text]
13. Chen CH, Nakayama M, Nevo E, Fetics BJ, Maughan WL, Kass DA. Coupled systolic-ventricular and vascular stiffening with age implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol. 1998;32:1221–1227[Abstract/Free Full Text]
14. Senzaki H, Chen CH, Kass DA. Single-beat estimation of end-systolic pressure-volume relation in humans: A new method with the potential for noninvasive application. Circulation. 1996;94:2497–2506[Abstract/Free Full Text]
15. Takeuchi M, Igarash Y, Tomimoto S, et al. Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle. Circulation. 1991;83:202–212[Abstract/Free Full Text]
16. Shishido T, Hayashi K, Shigemi K, Sato T, Sugimachi M, Sunagawa K. Single-beat estimation of end-systolic elastance using bilinearly approximated time-varying elastance curve (in process citation). Circulation. 2000;102:1983–1989[Abstract/Free Full Text]
17. Setser R, Henson RE, Allen JS, Fischer SE, Wickline SA, Loren CH. Left ventricular contractility is impaired following myocardial infarction in the pig and rat: Assessment by the end systolic pressure-volume relation using a single-beat estimation technique and cine magnetic resonance imaging. Ann Biomed Eng. 2000;28:484–494[CrossRef][Medline]
18. Lee DS, Kim KM, Kim SK, et al. Development of a method for measuring myocardial contractility with gated myocardial SPECT and arterial tonometry. J Nucl Cardiol. 1999;6:657–663[CrossRef][Medline]
19. Kelly RP, Ting CT, Yang TM, et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation. 1992;86:513–521[Abstract/Free Full Text]
20. Dubin J, Wallerson DC, Cody RJ, Devereux RB. Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination. Am Heart J. 1990;120:116–123[CrossRef][Medline]
21. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determination: Echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1976;37:7–12[CrossRef][Medline]
22. Pak PH, Maughan WLM, Baughman KL, Kieval RS, Kass DA. Mechanisms of acute mechanical benefit from VDD pacing in hypertrophic heart disease. Circulation. 1998;98:242–248[Abstract/Free Full Text]
23. Chen CH, Nevo E, Fetics B, et al. Comparison of continuous left ventricular volumes by transthoracic two-dimensional digital echo-quantification with simultaneous conductance catheter measurement in patients with cardiac diseases. Am J Cardiol. 1997;80:756–761[CrossRef][Medline]
24. Karunanithi MK, Feneley MP. Single-beat determination of preload recruitable stroke work relationship: Derivation and evaluation in conscious dogs. J Am Coll Cardiol. 2000;35:502–513[Abstract/Free Full Text]
25. Eur Heart J. 1992;13(Suppl E):
This article has been cited by other articles:
|
|
|
|
 
D. Burkhoff
Chasing the Elusive Pressure-Volume Relationships
J. Am. Coll. Cardiol. Img.,
November 1, 2009;
2(11):
1282 - 1284.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Chirinos, E. R. Rietzschel, M. L. De Buyzere, D. De Bacquer, T. C. Gillebert, A. K. Gupta, P. Segers, and on behalf of the Asklepios investigators
Arterial Load and Ventricular-Arterial Coupling: Physiologic Relations With Body Size and Effect of Obesity
Hypertension,
September 1, 2009;
54(3):
558 - 566.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. T. Phan, K. Abozguia, G. Nallur Shivu, G. Mahadevan, I. Ahmed, L. Williams, G. Dwivedi, K. Patel, P. Steendijk, H. Ashrafian, et al.
Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.
J. Am. Coll. Cardiol.,
July 28, 2009;
54(5):
402 - 409.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Borlaug, C. S.P. Lam, V. L. Roger, R. J. Rodeheffer, and M. M. Redfield
Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.
J. Am. Coll. Cardiol.,
July 28, 2009;
54(5):
410 - 418.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E.-Y. Choi, B. W. Choi, S.-A. Kim, S. J. Rhee, C. Y. Shim, Y. J. Kim, S.-M. Kang, J.-W. Ha, and N. Chung
Patterns of late gadolinium enhancement are associated with ventricular stiffness in patients with advanced non-ischaemic dilated cardiomyopathy
Eur J Heart Fail,
June 1, 2009;
11(6):
573 - 580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kurt, J. Wang, G. Torre-Amione, and S. F. Nagueh
Left Atrial Function in Diastolic Heart Failure
Circ Cardiovasc Imaging,
January 1, 2009;
2(1):
10 - 15.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Antonini-Canterin, S. Carerj, V. Di Bello, G. Di Salvo, S. La Carrubba, O. Vriz, D. Pavan, A. Balbarini, G. L. Nicolosi, and On behalf of the Research Group of the Italian Soc
Arterial stiffness and ventricular stiffness: a couple of diseases or a coupling disease? A review from the cardiologist's point of view
Eur J Echocardiogr,
January 1, 2009;
10(1):
36 - 43.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Zanon, S. Aggio, E. Baracca, G. Pastore, G. Corbucci, G. Boaretto, G. Braggion, C. Piergentili, G. Rigatelli, and L. Roncon
Ventricular-arterial coupling in patients with heart failure treated with cardiac resynchronization therapy: may we predict the long-term clinical response?
Eur J Echocardiogr,
January 1, 2009;
10(1):
106 - 111.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-M. Cheng, W.-C. Yu, S.-H. Sung, K.-L. Wang, S.-Y. Chuang, and C.-H. Chen
Usefulness of systolic time intervals in the identification of abnormal ventriculo-arterial coupling in stable heart failure patients
Eur J Heart Fail,
December 1, 2008;
10(12):
1192 - 1200.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Chantler, E. G. Lakatta, and S. S. Najjar
Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise
J Appl Physiol,
October 1, 2008;
105(4):
1342 - 1351.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. V. Dinh, J. Alvergue, J. Sayre, J. S. Child, V. S. Deshpande, G. Laub, and J. P. Finn
Isovolumic Cardiac Contraction on High-Temporal-Resolution Cine MR Images: Study in Heart Failure Patients and Healthy Volunteers
Radiology,
August 1, 2008;
248(2):
458 - 465.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N C Edwards, C J Ferro, J N Townend, and R P Steeds
Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction
Heart,
August 1, 2008;
94(8):
1038 - 1043.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Chantler, V. Melenovsky, S. P. Schulman, G. Gerstenblith, L. C. Becker, L. Ferrucci, J. L. Fleg, E. G. Lakatta, and S. S. Najjar
The sex-specific impact of systolic hypertension and systolic blood pressure on arterial-ventricular coupling at rest and during exercise
Am J Physiol Heart Circ Physiol,
July 1, 2008;
295(1):
H145 - H153.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Osranek, J. H. Eisenach, B. K. Khandheria, K. Chandrasekaran, J. B. Seward, and M. Belohlavek
Arterioventricular Coupling and Ventricular Efficiency After Antihypertensive Therapy: A Noninvasive Prospective Study
Hypertension,
February 1, 2008;
51(2):
275 - 281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-M. Tartiere, L. Tartiere-Kesri, and A. Cohen Solal
Letter by Tartiere et al Regarding Article, "Cardiac Structure and Ventricular Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota"
Circulation,
December 11, 2007;
116(24):
e562 - e562.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S.P. Lam, V. L. Roger, R. J. Rodeheffer, B. A. Borlaug, S. R. Ommen, M. M. Redfield, F. Bursi, and D. A. Kass
Response to Letter Regarding Article, "Cardiac Structure and Ventricular Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota"
Circulation,
December 11, 2007;
116(24):
e563 - e563.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S.P. Lam, V. L. Roger, R. J. Rodeheffer, F. Bursi, B. A. Borlaug, S. R. Ommen, D. A. Kass, and M. M. Redfield
Cardiac Structure and Ventricular-Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota
Circulation,
April 17, 2007;
115(15):
1982 - 1990.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Knaapen, T. Germans, J. Knuuti, W. J. Paulus, P. A. Dijkmans, C. P. Allaart, A. A. Lammertsma, and F. C. Visser
Myocardial Energetics and Efficiency: Current Status of the Noninvasive Approach
Circulation,
February 20, 2007;
115(7):
918 - 927.
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Melenovsky, B. A. Borlaug, B. Rosen, I. Hay, L. Ferruci, C. H. Morell, E. G. Lakatta, S. S. Najjar, and D. A. Kass
Cardiovascular Features of Heart Failure With Preserved Ejection Fraction Versus Nonfailing Hypertensive Left Ventricular Hypertrophy in the Urban Baltimore Community: The Role of Atrial Remodeling/Dysfunction
J. Am. Coll. Cardiol.,
January 16, 2007;
49(2):
198 - 207.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Thomas and Z. B. Popovic
Assessment of Left Ventricular Function by Cardiac Ultrasound
J. Am. Coll. Cardiol.,
November 21, 2006;
48(10):
2012 - 2025.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Chung, A. Strunc, R. Oliver, and S. J. Kovacs
Diastolic ventricular-vascular stiffness and relaxation relation: elucidation of coupling via pressure phase plane-derived indexes
Am J Physiol Heart Circ Physiol,
November 1, 2006;
291(5):
H2415 - H2423.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Shibata, R. Zhang, J. Hastings, Q. Fu, K. Okazaki, K.-i. Iwasaki, and B. D. Levine
Cascade model of ventricular-arterial coupling and arterial-cardiac baroreflex function for cardiovascular variability in humans
Am J Physiol Heart Circ Physiol,
November 1, 2006;
291(5):
H2142 - H2151.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Klotz, I. Hay, M. L. Dickstein, G.-H. Yi, J. Wang, M. S. Maurer, D. A. Kass, and D. Burkhoff
Single-beat estimation of end-diastolic pressure-volume relationship: a novel method with potential for noninvasive application
Am J Physiol Heart Circ Physiol,
July 1, 2006;
291(1):
H403 - H412.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Redfield, S. J. Jacobsen, B. A. Borlaug, R. J. Rodeheffer, and D. A. Kass
Age- and Gender-Related Ventricular-Vascular Stiffening: A Community-Based Study
Circulation,
October 11, 2005;
112(15):
2254 - 2262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. de Santis, P. Abete, G. Testa, F. Cacciatore, G. Galizia, D. Leosco, L. Viati, V. D. Villano, D. D. Morte, F. Mazzella, et al.
Echocardiographic evaluation of left ventricular end-systolic elastance in the elderly
Eur J Heart Fail,
August 1, 2005;
7(5):
829 - 833.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Burkhoff, I. Mirsky, and H. Suga
Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers
Am J Physiol Heart Circ Physiol,
August 1, 2005;
289(2):
H501 - H512.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Uemura, T. Kawada, A. Kamiya, T. Aiba, I. Hidaka, K. Sunagawa, and M. Sugimachi
Prediction of circulatory equilibrium in response to changes in stressed blood volume
Am J Physiol Heart Circ Physiol,
July 1, 2005;
289(1):
H301 - H307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Schenk, Z. B. Popovic, Y. Ochiai, F. Casas, P. M. McCarthy, R. C. Starling, M. W. Kopcak Jr., R. Dessoffy, J. L. Navia, N. L. Greenberg, et al.
Preload-adjusted right ventricular maximal power: concept and validation
Am J Physiol Heart Circ Physiol,
October 1, 2004;
287(4):
H1632 - H1640.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Arbab-Zadeh, E. Dijk, A. Prasad, Q. Fu, P. Torres, R. Zhang, J. D. Thomas, D. Palmer, and B. D. Levine
Effect of Aging and Physical Activity on Left Ventricular Compliance
Circulation,
September 28, 2004;
110(13):
1799 - 1805.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-H. Chen, Y.-P. Lin, W.-C. Yu, W.-C. Yang, and Y.-A. Ding
Volume Status and Blood Pressure During Long-Term Hemodialysis: Role of Ventricular Stiffness
Hypertension,
September 1, 2003;
42(3):
257 - 262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kawaguchi, I. Hay, B. Fetics, and D. A. Kass
Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations
Circulation,
February 11, 2003;
107(5):
714 - 720.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-S. Lee, W.-P. Huang, W.-C. Yu, K.-R. Chiou, P. Y.-A. Ding, and C.-H. Chen
Estimation of preload recruitable stroke work relationship by a single-beat technique in humans
Am J Physiol Heart Circ Physiol,
February 1, 2003;
284(2):
H744 - H750.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. B. Popovic', K. A. Mowrey, Y. Zhang, S. Zhuang, T. Tabata, D. W. Wallick, R. A. Grimm, J. D. Thomas, and T. N. Mazgalev
Slow rate during AF improves ventricular performance by reducing sensitivity to cycle length irregularity
Am J Physiol Heart Circ Physiol,
December 1, 2002;
283(6):
H2706 - H2713.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
Top
Abstract
Methods
Ees) induced by dobutamine determined by noninvasive estimation versus the directly assessed value derived from invasive pressure-volume loops. The noninvasive method provided a good estimate of